This document, which is subject to regular updates, provides best practice evidence informed perspectives for ophthalmologists in Canada and can be viewed as a supplement to the June 3, 2020 COS issued document entitled “Immediately Sequential Bilateral Cataract Surgery (ISBCS) – Key Points”. (Appendix 1).
DISCLAIMER: This document should not be viewed as advocating widespread adoption of ISBCS; however, if individuals or groups are considering this or already engaging in the practice in the context of the COVID-19 pandemic, then we hope that the perspectives shared will be helpful. It will be important for those doing ISBCS to follow best practice recommendations so as to optimize outcomes and minimize the risk of complications. It is also important to note that standards of ISBCS and restrictions due to COVID are evolving and all surgeons must stay updated and use clinical acumen and judgement when deciding what is best- care for their patients.
Glaucoma is one of the leading causes of blindness worldwide - New study identifies 127 Glaucoma Genes, a breakthrough in Glaucoma research.
127 Glaucoma Genes Identified in Largest Study of Its Kind technologynetworks.com/genomi…
REMINDER: Today is the last day to register for #AGS2021. Don't miss out on this unique opportunity to access live broadcasts, exhibits & networking with some of the top Glaucoma specialists from around the world, all online. mailchi.mp/aao/ags-2021-p…. @AGSDocs
Can Ophthal Society's Twitter via Twitter Web Client
Redirecting to a Third-Party Website
You are now temporarily leaving the Practice Resource Centre. Clicking the button below will open a third-party website in a new browser tab. The website you are being redirected to is published by a third party and as such, its content is not under the control of the COS.